These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 17159922

  • 1. Multi-targeting by monotherapeutic antibacterials.
    Silver LL.
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [Abstract] [Full Text] [Related]

  • 2. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT, Hodgson J.
    Adv Drug Deliv Rev; 2005 Jul 29; 57(10):1528-38. PubMed ID: 15949866
    [Abstract] [Full Text] [Related]

  • 3. Targeting non-multiplying organisms as a way to develop novel antimicrobials.
    Coates AR, Hu Y.
    Trends Pharmacol Sci; 2008 Mar 29; 29(3):143-50. PubMed ID: 18262665
    [Abstract] [Full Text] [Related]

  • 4. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
    Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL.
    Nat Rev Drug Discov; 2007 Jan 29; 6(1):29-40. PubMed ID: 17159923
    [Abstract] [Full Text] [Related]

  • 5. Whither antibacterial drug discovery?
    Projan SJ.
    Drug Discov Today; 2008 Apr 29; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract] [Full Text] [Related]

  • 6. Old and new targets of antibacterial therapy.
    Dbaibo GS.
    J Med Liban; 2000 Apr 29; 48(4):177-81. PubMed ID: 11214186
    [Abstract] [Full Text] [Related]

  • 7. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P, Pizza M.
    Curr Opin Microbiol; 2008 Oct 29; 11(5):385-6. PubMed ID: 18804177
    [No Abstract] [Full Text] [Related]

  • 8. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ, Bradford PA.
    Curr Opin Microbiol; 2007 Oct 29; 10(5):441-6. PubMed ID: 17950658
    [Abstract] [Full Text] [Related]

  • 9. What is inadequate antibacterial therapy?
    Moellering RC.
    Clin Infect Dis; 2009 Oct 01; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [New targets in the field of antibacterial agents. Prospective aspects].
    Desnottes JF.
    Ann Pharm Fr; 1999 Mar 01; 57(2):177-82. PubMed ID: 10365475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS.
    Clin Infect Dis; 2010 Sep 15; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD, Heddini A, Cars O.
    Trends Pharmacol Sci; 2010 Nov 15; 31(11):509-15. PubMed ID: 20843562
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Challenges of antibacterial discovery revisited.
    Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ.
    Ann N Y Acad Sci; 2010 Dec 15; 1213():5-19. PubMed ID: 21058956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.